Belgium· BE-AMP-SAM591937-00
Ronapreve 300 mg - 300 mg
A casirivimab and imdevimab product containing imdevimab, registered in Belgium by Roche Registration. The same ATC class is registered in 5 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Casirivimab and imdevimab is registered in 5 of 19 countries.
Countries holding a registration under ATC J06BD07 (casirivimab and imdevimab), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Casirivimab and imdevimab · ATC J06BD07
5 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Polandprice
- Spainprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Imdevimab
- Manufacturer
- Roche Registration
- Country
- Belgium (BE)
- ATC code
- J06BD07
- ATC class
- Casirivimab and imdevimab
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Casirivimab and imdevimab in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac9124e5-6dc6-4827-9c10-879e9e7a014a GET /v1/drugs/ac9124e5-6dc6-4827-9c10-879e9e7a014a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection/infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Ronapreve 300 mg - 300 mg",
"name_fr": "Ronapreve 300 mg - 300 mg",
"name_nl": "Ronapreve 300 mg - 300 mg",
"amp_code": "SAM591937-00",
"strengths": [
"120.0000",
"120.0000",
"120.0000",
"120.0000"
],
"pack_count": 1,
"substances": [
"Imdevimab",
"Sucrose",
"Polysorbate 80",
"Casirivimab"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Casirivimab and Imdevimab",
"authorisation_numbers": [
"EU/1/21/1601/001"
]
}See everything about casirivimab and imdevimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.